LI
WST icon

LRI Investments’s West Pharmaceutical WST Stock Holding History

LRI Investments’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.3K Buy
246
+4
+2% +$1.22K 0.01% 463
2026
Q1 		$60.7K Buy
242
+24
+11% +$5.97K 0.01% 487
2025
Q4 		$60K Hold
218
– – ﹤0.01% 511
2025
Q3 		$57.2K Hold
218
– – ﹤0.01% 529
2025
Q2 		$47.7K Hold
218
– – ﹤0.01% 559
2025
Q1 		$48.8K Hold
218
– – ﹤0.01% 535
2024
Q4 		$71.4K Hold
218
– – 0.01% 472
2024
Q3 		$73.7K Hold
218
– – 0.01% 467
2024
Q2 		$71.8K Hold
218
– – 0.01% 439
2024
Q1 		$86.3K Buy
+218
New +$80.6K 0.02% 219

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
DC
Davenport & Co Richmond, Virginia $19.6B AUM 18.11% 1-Year Est. Return